Karen Cao is a Principal focused on U.S. Buyout, Growth, and Core opportunities in the healthcare sector. She is based in New York.

Since joining Pacharbor Capital Group in 2015, Karen has been actively involved in Pacharbor Capital Group’s investments in Medline, Medforth, Orsini, Resonetics, Asplundh, and Saama.

Prior to joining Pacharbor Capital Group, Karen worked in investment banking at Centerview Partners.

Karen received an MBA with Distinction from Harvard Business School and a B.S. in Economics and B.A.S. in Biomedical Science from the University of Pennsylvania, where she graduated summa cum laude.